SI20074A - 1-(3-aminoindazol-5-il)-3-fenilmetil-ciklične sečnine, uporabne kot inhibitorji proteaze HIV - Google Patents

1-(3-aminoindazol-5-il)-3-fenilmetil-ciklične sečnine, uporabne kot inhibitorji proteaze HIV Download PDF

Info

Publication number
SI20074A
SI20074A SI9720072A SI9720072A SI20074A SI 20074 A SI20074 A SI 20074A SI 9720072 A SI9720072 A SI 9720072A SI 9720072 A SI9720072 A SI 9720072A SI 20074 A SI20074 A SI 20074A
Authority
SI
Slovenia
Prior art keywords
compound
hiv
formula
compounds
reverse transcriptase
Prior art date
Application number
SI9720072A
Other languages
English (en)
Slovenian (sl)
Inventor
James David Rodgers
Robert Frank Kaltenbach Iii
Original Assignee
Dupont Pharmaceuticals Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Pharmaceuticals Company filed Critical Dupont Pharmaceuticals Company
Publication of SI20074A publication Critical patent/SI20074A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI9720072A 1996-11-08 1997-11-04 1-(3-aminoindazol-5-il)-3-fenilmetil-ciklične sečnine, uporabne kot inhibitorji proteaze HIV SI20074A (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2974596P 1996-11-08 1996-11-08
US74710496A 1996-11-08 1996-11-08
PCT/US1997/020035 WO1998020008A1 (fr) 1996-11-08 1997-11-04 Urees 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cycliques utiles en tant qu'inhibiteurs de protease de vih

Publications (1)

Publication Number Publication Date
SI20074A true SI20074A (sl) 2000-04-30

Family

ID=26705293

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9720072A SI20074A (sl) 1996-11-08 1997-11-04 1-(3-aminoindazol-5-il)-3-fenilmetil-ciklične sečnine, uporabne kot inhibitorji proteaze HIV

Country Status (21)

Country Link
EP (1) EP0937067B1 (fr)
JP (1) JP2001503428A (fr)
KR (1) KR20000053122A (fr)
CN (1) CN1235602A (fr)
AT (1) ATE244714T1 (fr)
AU (1) AU5165198A (fr)
BR (1) BR9712910A (fr)
CA (1) CA2270966A1 (fr)
CZ (1) CZ157599A3 (fr)
DE (1) DE69723456T2 (fr)
EA (1) EA199900452A1 (fr)
EE (1) EE9900188A (fr)
ES (1) ES2202645T3 (fr)
HU (1) HUP9904676A2 (fr)
IL (1) IL129727A0 (fr)
LV (1) LV12375B (fr)
NO (1) NO992228L (fr)
PL (1) PL333421A1 (fr)
SI (1) SI20074A (fr)
SK (1) SK59699A3 (fr)
WO (1) WO1998020008A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6870098A (en) * 1997-03-31 1998-10-22 Du Pont Merck Pharmaceutical Company, The Indazoles of cyclic ureas useful as hiv protease inhibitors
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
CN101415685B (zh) 2006-01-31 2011-08-24 阿雷生物药品公司 激酶抑制剂及其使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5532357A (en) * 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas

Also Published As

Publication number Publication date
KR20000053122A (ko) 2000-08-25
EP0937067A1 (fr) 1999-08-25
EP0937067B1 (fr) 2003-07-09
DE69723456T2 (de) 2004-05-27
ATE244714T1 (de) 2003-07-15
DE69723456D1 (de) 2003-08-14
EE9900188A (et) 1999-12-15
BR9712910A (pt) 2000-03-21
LV12375A (lv) 1999-11-20
PL333421A1 (en) 1999-12-06
ES2202645T3 (es) 2004-04-01
CA2270966A1 (fr) 1998-05-14
AU5165198A (en) 1998-05-29
IL129727A0 (en) 2000-02-29
EA199900452A1 (ru) 2000-02-28
CZ157599A3 (cs) 1999-11-17
WO1998020008A1 (fr) 1998-05-14
NO992228L (no) 1999-06-07
CN1235602A (zh) 1999-11-17
NO992228D0 (no) 1999-05-07
SK59699A3 (en) 1999-12-10
HUP9904676A2 (hu) 2000-06-28
LV12375B (en) 2000-04-20
JP2001503428A (ja) 2001-03-13

Similar Documents

Publication Publication Date Title
US6204262B1 (en) 1,3-Benzodiazepin-2-ones and 1,3-Benzoxazepin-2-ones useful as HIV reverse transcriptase inhibitors
SI20074A (sl) 1-(3-aminoindazol-5-il)-3-fenilmetil-ciklične sečnine, uporabne kot inhibitorji proteaze HIV
US5932570A (en) 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
SI9720071A (sl) 1-(3-aminoindazol-5-il)-3-butil-ciklična sečnina, uporabna kot inhibitor proteaze HIV
US6218386B1 (en) A1-(3-aminoindazol-5-yl)-3 butyl-cyclic urea useful as a HIV protease inhibitor
US6313110B1 (en) Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor
AU2725700A (en) Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors
US6946469B2 (en) Cyanamide, alkoxyamino, and urea derivatives of 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones as HIV reverse transcriptase inhibitors
US20020022742A1 (en) Salt forms of an HIV protease inhibitor
US7015214B2 (en) Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazepine as HIV reverse transcriptase inhibitors
LT4676B (lt) 1-(3-aminoindazol-5-il)-3-fenilmetil-cikliniai karbamidai, naudojami kaip živ proteazės inhibitoriai
WO2004043911A2 (fr) N-cycloalkylglycines utilises comme inhibiteurs de protease de vih
MXPA99004286A (en) 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors
US20020022659A1 (en) Crystalline and salt forms of an HIV protease inhibitor
HRP970595A2 (en) 1-(3-aminoindazol-5-yl)-3-butyl-cyclic urea useful as a hiv proteaze inhibitor
MXPA99004294A (en) (4r,5s,6s,7r)-hexahydro-1- [5-(3-aminoinazole)methyl]-3-butyl-5,6-dihydroxy-4,7-bis [phaenylmethyl]-2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor
US20060128634A1 (en) Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors
MXPA01007047A (en) Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors